Kwangdong Pharmaceutical: "Main Contract for Jeju Samdasoo Proceeding Smoothly Without Issues"

Kwangdong Pharmaceutical stated that detailed discussions for the signing of the main contract with Jeju Special Self-Governing Province Development Corporation have begun and are proceeding smoothly without any issues.

On September 2, Kwangdong Pharmaceutical clarified that the report by a certain media outlet titled "Jeju Development Corporation-Kwangdong Pharmaceutical, Delay in Main Contract for Jeju Samdasoo" is not true.

The company explained that negotiations for the main contract regarding the consignment sales of Jeju Samdasoo, currently underway with Jeju Special Self-Governing Province Development Corporation, began last week by mutual agreement between the two parties. The final contract will be signed after detailed discussions are completed.

As the consignment sales contract for Jeju Samdasoo in regions outside Jeju requires careful review and discussion of various matters such as supply volume and distribution strategy, it is standard practice to conduct thorough negotiations.

A Kwangdong Pharmaceutical representative stated, "Detailed discussions for the signing of the main contract began last week and are proceeding without any issues," adding, "Claims of negotiation delays raised by some are not true."

This content was produced with the assistance of AI translation services.